![What Is The 20 Mg Cbd Gummy Effect? A Practical Guide For Daily Wellness [RZt4r4GSxDV]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-30801250-150x150.jpg "What Is The 20 Mg Cbd Gummy Effect? A Practical Guide For Daily Wellness [RZt4r4GSxDV] 23")
The Wait is Over: Medical Cannabis Set to Roll Out in Alabama in April
Alabama medical cannabis program is moving forward with an official rollout planned for April. This program will expand patient access to cannabis therapeutics under state regulations. Physicians should prepare to integrate Alabama medical cannabis…
GLP-1 Medications Get at the Heart of Addiction, Study Finds
GLP-1 medications addiction treatment shows promise in reducing cannabis use disorder alongside other substance use disorders. These medications may address multiple addiction pathways simultaneously rather than targeting individual substances.…
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
NHS access barriers medical cannabis remain a critical issue for pediatric drug-resistant epilepsy patients in the UK. Despite legal changes, many children cannot access cannabinoid therapies through the NHS. This campaign highlights the urgent need for…
Daily Digest: Last 18 Hours: Cannabis Impairment Testing, Brain Aging, and the Race for Better Evidence — March 05, 2026
A synthesis of 6 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.
Pres. Trump’s Executive Mandate Speeds DEA Licensing for Cannabis Research
DEA licensing cannabis research is accelerating due to recent executive actions. This change addresses longstanding regulatory delays that have hindered clinical investigation. The streamlined approval process is expected to expand research on cannabis…
Omagh Biotech Start-Up Boosts Research into Obesity and Epilepsy
Sonas Pharma’s funding boost advances endocannabinoid system obesity epilepsy research. This biotech aims to develop targeted therapeutics for these challenging conditions. The focus on endocannabinoid system obesity epilepsy offers hope for improved…
What to Know About How GLP-1 Medications Might Fight Addiction – The Washington Post
GLP-1 receptor agonist addiction treatment shows promise as a novel approach for substance use disorders. These medications, already used for metabolic diseases, may reduce cravings by affecting brain reward pathways. Ongoing research is crucial to…
Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
This digest reviews recent findings on cannabis and cognitive aging, highlighting reassuring safety data for older adults. It also addresses adolescent cannabis exposure risks and ongoing policy reform challenges. The focus on cannabis and cognitive…
What a Major Study Reveals About Cannabis Use and Brain Aging
Cannabis use and brain aging is a complex relationship explored in a major study using large biobank datasets. The research suggests initial differences in brain age metrics among cannabis users but no straightforward harmful or protective effects. This…
Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de
Endocannabinoid system modulators AGTX-2004 and AGTX-2003 are advancing through clinical development, attracting significant investor focus. These cannabinoid-based therapeutics may offer new treatment options pending clinical validation. Clinicians…